Aurobindo Pharma Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1986

Chairman: K Ragunathan

Managing Director: N Govindarajan

Group: Aurobindo

Listing: NSE: AUROPHARMA, BSE: 524804

Headquarters: Hyderabad, Telangana

Website: www.aurobindo.com

Key Facts

Market cap: R 29,537.17 Cr

Revenue (TTM): R 22,232.27 Cr

Earnings (TTM): R 2,562.12 Cr

Cash: R 1,957.20 Cr

Total Debt: R 6,966.76 Cr

Promoters' ownership: 51.87%

Liquidity: High

52 Week range: R 389.35 - 838.00

Face value: R1.00

Shares outstanding: 58,59,38,609

Stock Performance

Trailing
Annual

Time Period	Aurobindo Pharma	S&P BSE Healthcare	S&P BSE Mid Cap
YTD	10.32	5.78	3.18
1 month	0.58	0.69	-2.39
3 months	17.52	6.01	4.79
1 Year	-30.93	4.54	8.94
3 Years	-8.88	-2.53	4.50
5 Years	-0.58	-1.98	7.56
10 Years	18.40	11.38	9.32

As on 24-Feb-2020

Year	Aurobindo Pharma	S&P BSE Mid Cap	S&P BSE Healthcare
2019	-37.69	-3.05	-3.55
2018	6.50	-13.31	-5.89
2017	2.79	48.13	0.49
2016	-24.06	7.97	-12.88
2015	55.43	7.43	15.06
2014	189.94	54.69	47.43
2013	103.05	-5.73	22.55

Annual Report (FY18)

Review & Analysis

Two attractive blue chip stocks in the mid cap space
Jugal Harpalani . 22-Nov-2019
Multibaggers of the decade
Yash Rohra . 16-Sep-2019
Large caps at a bargain
Jugal Harpalani . 21-Aug-2019
Big shifts
Research Desk . 04-Jul-2018
Picking cold stocks and converting them to cool ones
16-May-2018

News & Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript
24-Feb-2020
Further update on US FDA Inspection at our Unit IV
21-Feb-2020
Update On US FDA Inspection At Our Unit IV - Reg.
19-Feb-2020
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15-Feb-2020
Announcement under Regulation 30 (LODR)-Updates on Acquisition
12-Feb-2020